Neoadjuvant Therapy in Non–Small Cell Lung Cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Surgery
Reference60 articles.
1. World Health Organization, Media Centre. Cancer. 2015. Available at: http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed October 7, 2015.
2. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer;Chansky;J Thorac Oncol,2009
3. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumors;Goldstraw;J Thorac Oncol,2007
4. Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group;Sugarbaker;J Thorac Cardiovasc Surg,1995
5. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study;Strauss;J Clin Oncol,1992
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Non-neuroendocrine carcinomas (excluding sarcomatoid carcinoma) and salivary gland-type tumors of the lung;Practical Pulmonary Pathology;2024
2. Imaging procedures in the assessment of response to neoadjuvant treatment in non-small cell lung cancer;AME Surgical Journal;2023-04
3. Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial;Journal of Thoracic Oncology;2023-02
4. Major pathological response exhibited distinct prognostic significance for lung adenocarcinoma post different modalities of neoadjuvant therapy;Histopathology;2023-01-23
5. Trimodal Therapy and Surgical Approaches in Stage Iiia/N2 Non-Small Cell Lung Cancer;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3